Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators

Molecular Endocrinology

Volumn 15, Issue 2, 2001, Pages 219-227

  De Bosscher, K ^a   Berghe, W V ^a   Haegeman, G ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 0035147033     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.2.0591     Document Type: Article

References (53)

1. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
2. Interactions of coiled coils in transcription factors: Where is the specificity?
3. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
4. Activation of cAMP and mitogen-responsive genes relies on a common nuclear factor
5. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro
6. The CBP co-activator is a histone acetyltransferase
7. The transcriptional coactivators p300 and CBP are histone acetyltransferases
8. Steroid receptor coactivator-1 is a histone acetyltransferase
9. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
10. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
11. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
12. The pathophysiologic roles of interleukin-6 in human disease
13. Molecular and cellular biology of interleukin-6 and its receptor
14. Transrepression of c-Jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-Jun promoter
15. DNA binding of the glucocorticoid receptor is not essential for survival
16. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in the skin
17. Coactivator and corepressor complexes in nuclear receptor function
18. Steroid receptor coactivator-1 coactivates activating protein-1 mediated transactivations through interaction with the c-Jun and c-Fos subunits
19. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
20. Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP
21. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell
22. The nuclear factor-κ B engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter
23. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells
24. CBP-induced stimulation of c-Fos activity is abrogated by E1A
25. CREB-binding protein/p300 are transcriptional coactivators of p65
26. Achieving transcriptional specificity with NF-κB
27. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes
28. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
29. Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription
30. Molecular mechanisms of antiinflammatory action of glucocorticoids
31. Transcriptional crosstalk, the second mode of steroid hormone receptor action
32. CREB-binding protein in androgen receptor-mediated signaling
33. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1
34. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
35. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
36. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element
37. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element
38. Role of the composite glucocorticoid response element in proliferin gene expression
39. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors
40. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by an NF-κ-B-dependent mechanism
41. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
42. Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus
43. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation
44. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation
45. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
46. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
47. Allosteric effects of DNA on transcriptional regulators
48. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor
49. Glucocorticoidmediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation
50. Peroxisome proliferator-activated receptor-α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κ B and AP-1
51. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
52. A new technique for the assay of infectivity of human adenovirus 5 DNA
53. Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor